{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:35:52Z","timestamp":1791916552752,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":703,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1596\/neo.12230","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:10:48Z","timestamp":1429794648000},"page":"547-IN22","source":"Crossref","is-referenced-by-count":32,"title":["A Requirement for SOCS-1 and SOCS-3 Phosphorylation in Bcr-Abl-Induced Tumorigenesis"],"prefix":"10.1016","volume":"14","author":[{"given":"Xiaoxue","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kashiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Druker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1596\/neo.12230_bib1","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J Immunol"},{"key":"10.1596\/neo.12230_bib2","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/sj.onc.1203484","article-title":"JAK-STAT signaling activated by Abl oncogenes","volume":"19","author":"Danial","year":"2000","journal-title":"Oncogene"},{"key":"10.1596\/neo.12230_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.20062335","article-title":"Oncogenic signaling: new insights and controversies from chronic myeloid leukemia","volume":"204","author":"Van Etten","year":"2007","journal-title":"J Exp Med"},{"key":"10.1596\/neo.12230_bib4","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","article-title":"Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML","volume":"118","author":"Helgason","year":"2011","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib5","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.4049\/jimmunol.159.10.4720","article-title":"Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients","volume":"159","author":"Chai","year":"1997","journal-title":"J Immunol"},{"key":"10.1596\/neo.12230_bib6","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia","volume":"13","author":"Shuai","year":"1996","journal-title":"Oncogene"},{"key":"10.1596\/neo.12230_bib7","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members","volume":"271","author":"Ilaria","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1596\/neo.12230_bib8","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1038\/sj.onc.1204834","article-title":"Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation","volume":"20","author":"Xie","year":"2001","journal-title":"Oncogene"},{"key":"10.1596\/neo.12230_bib9","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-06-0025","article-title":"Janus kinase 2: a critical target in chronic myelogenous leukemia","volume":"66","author":"Samanta","year":"2006","journal-title":"Cancer Res"},{"key":"10.1596\/neo.12230_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/leu.2010.287","article-title":"Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia","volume":"25","author":"Samanta","year":"2011","journal-title":"Leukemia"},{"key":"10.1596\/neo.12230_bib11","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood-2009-10-248211","article-title":"High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia","volume":"117","author":"Warsch","year":"2011","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib12","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of Bcr\/Abl-positive leukaemia","volume":"2","author":"Hoelbl","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1596\/neo.12230_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1074\/jbc.R300030200","article-title":"Inhibitors of cytokine signal transduction","volume":"279","author":"Wormald","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1596\/neo.12230_bib15","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1073\/pnas.96.5.2071","article-title":"The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation","volume":"96","author":"Zhang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1596\/neo.12230_bib16","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/MCB.22.10.3316-3326.2002","article-title":"Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1","volume":"22","author":"Ungureanu","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1596\/neo.12230_bib17","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.4049\/jimmunol.178.8.5058","article-title":"Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist","volume":"178","author":"Waiboci","year":"2007","journal-title":"J Immunol"},{"key":"10.1596\/neo.12230_bib18","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","article-title":"SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma","volume":"101","author":"Galm","year":"2003","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0501-29","article-title":"SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity","volume":"28","author":"Yoshikawa","year":"2001","journal-title":"Nat Genet"},{"key":"10.1596\/neo.12230_bib20","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/0008-5472.CAN-06-1627","article-title":"Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1","volume":"67","author":"Saudemont","year":"2007","journal-title":"Cancer Res"},{"key":"10.1596\/neo.12230_bib21","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib22","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1596\/neo.12230_bib23","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib24","doi-asserted-by":"crossref","first-page":"14133","DOI":"10.1073\/pnas.2232790100","article-title":"SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer","volume":"100","author":"He","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1596\/neo.12230_bib25","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1038\/sj.onc.1208788","article-title":"Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK\/STAT and FAK signalings in human hepatocellular carcinoma","volume":"24","author":"Niwa","year":"2005","journal-title":"Oncogene"},{"key":"10.1596\/neo.12230_bib26","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1038\/sj.onc.1208818","article-title":"SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition","volume":"24","author":"Weber","year":"2005","journal-title":"Oncogene"},{"key":"10.1596\/neo.12230_bib27","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ijc.24172","article-title":"SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL","volume":"124","author":"Barclay","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1596\/neo.12230_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.leu.2403610","article-title":"Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFN\u03b1","volume":"19","author":"Brender","year":"2005","journal-title":"Leukemia"},{"key":"10.1596\/neo.12230_bib29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1365-2141.2003.04660.x","article-title":"Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia","volume":"123","author":"Liu","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1596\/neo.12230_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ajh.20886","article-title":"The SOCS-1 gene methylation in chronic myeloid leukemia patients","volume":"82","author":"Hatirnaz","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1596\/neo.12230_bib31","first-page":"42","article-title":"The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-\u03b1","volume":"89","author":"Roman-Gomez","year":"2004","journal-title":"Haematologica"},{"key":"10.1596\/neo.12230_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/35074525","article-title":"Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras","volume":"3","author":"Cacalano","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1596\/neo.12230_bib33","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1182\/blood-2006-08-039735","article-title":"The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3","volume":"109","author":"Hookham","year":"2007","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3324\/haematol.2008.002352","article-title":"SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases","volume":"94","author":"Elliott","year":"2009","journal-title":"Haematologica"},{"key":"10.1596\/neo.12230_bib35","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1073\/pnas.042035699","article-title":"Pim serine\/threonine kinases regulate the stability of Socs-1 protein","volume":"99","author":"Chen","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1596\/neo.12230_bib36","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/onc.2010.149","article-title":"Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cells","volume":"29","author":"Guo","year":"2010","journal-title":"Oncogene"},{"key":"10.1596\/neo.12230_bib37","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2007-04-083808","article-title":"Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.molcel.2004.06.041","article-title":"v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells","volume":"15","author":"Limnander","year":"2004","journal-title":"Mol Cell"},{"key":"10.1596\/neo.12230_bib39","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/leu.2008.126","article-title":"Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells","volume":"22","author":"MacPartlin","year":"2008","journal-title":"Leukemia"},{"key":"10.1596\/neo.12230_bib40","doi-asserted-by":"crossref","first-page":"12967","DOI":"10.1073\/pnas.0805073105","article-title":"Suppression of E-protein activity interferes with the development of BCR-Abl-mediated myeloproliferative disease","volume":"105","author":"Ko","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1596\/neo.12230_bib41","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1074\/jbc.M010074200","article-title":"The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2","volume":"276","author":"Kamizono","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1596\/neo.12230_bib42","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","article-title":"Bcr\/Abl activates transcription of the Bcl-X gene through STAT5","volume":"96","author":"Gesbert","year":"2000","journal-title":"Blood"},{"key":"10.1596\/neo.12230_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/ar1741","article-title":"Negative regulation of cytokine signaling and immune responses by SOCS proteins","volume":"7","author":"Yoshimura","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1596\/neo.12230_bib44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1596\/neo.12230_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cellsig.2008.11.002","article-title":"Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation","volume":"21","author":"Boyle","year":"2009","journal-title":"Cell Signal"},{"key":"10.1596\/neo.12230_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1751-553X.2009.01143.x","article-title":"Prognostic relevance of 9q34 deletion and the suppressor of cytokine signalling-1 in CML patients","volume":"32","author":"Ghaith","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1596\/neo.12230_bib47","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/blood-2002-01-0073","article-title":"Constitutive expression of SOCS3 confers resistance to IFN-\u03b1 in chronic myelogenous leukemia cells","volume":"100","author":"Sakai","year":"2002","journal-title":"Blood"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558612801102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558612801102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T18:52:17Z","timestamp":1691607137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558612801102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1476558612801102"],"URL":"https:\/\/doi.org\/10.1596\/neo.12230","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}